Prenatal Paternity Testing: CVS and Amniocentesis Options, Risks, and Timing

Establishing Paternity Before Birth

Two invasive prenatal tests can determine paternity with >99% accuracy. Both carry a small miscarriage risk (~0.1–0.3%) and are typically offered only when medically indicated or for compelling legal/personal reasons.

Chorionic Villus Sampling (CVS)

  • Timing: 10–13 weeks gestation.
  • Procedure: Transcervical or transabdominal catheter/needle samples placental chorionic villi.
  • DNA Source: Fetal (placental) cells.
  • Advantage: Earlier result.
  • Risk: ~0.2–0.5% miscarriage; rare limb reduction defects if done <10 weeks.

Amniocentesis

  • Timing: 15–20+ weeks.
  • Procedure: Transabdominal needle withdraws 20–30 mL amniotic fluid.
  • DNA Source: Fetal cells (amniocytes) in fluid.
  • Advantage: Lower miscarriage risk (~0.1–0.3%); also diagnoses neural tube defects (AFP).
  • Risk: Amniotic fluid leak, infection, Rh sensitization.

Non-Invasive Alternative

Cell-free fetal DNA (cffDNA) in maternal blood can determine paternity from ~9–10 weeks with no miscarriage risk. Not yet universally available for paternity; confirm lab accreditation.

Counseling Essential

Genetic counseling before testing to discuss risks, limitations, and implications.

Infertility - Related Articles